Raydiant Oximetry
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$30.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Raydiant Oximetry operates in Healthcare & Life Sciences and is based in San Ramon, California. Its latest recorded funding round was a Grant round in November 2024.
Raydiant Oximetry is a medical technology company that develops non-invasive fetal pulse oximetry sensors to monitor fetal oxygen levels during labor and delivery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Raydiant Oximetry Comparables
Compare Raydiant Oximetry with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Storx Technologies | 93% | |
| Walela | 85% | |
| Wavelet Medical | 82% |
For institutional investors. Book with your work email.
Raydiant Oximetry Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Sep 24, 2024 | ||||
| Series A Extension | Jun 4, 2024 | ||||
| Series B | Feb 7, 2023 | ||||
| Series A Extension | Nov 2, 2021 | ||||
Grant | May 26, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Raydiant Oximetry Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| KOFA Healthcare | Series A Extension |
| March of Dimes | Series B, Series A Extension |
| SteelSky Ventures | Series A Extension |
| Avestria Ventures | Series A, Series A Extension |
| Gates Foundation | Grant |
| Tara Health Foundation | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 42% MoM, from 807 to 1.1K.
- Nov 1, 2024
$750K grant received from multiple foundations and institutes.
For institutional investors. Book with your work email.
Raydiant Oximetry Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Raydiant Oximetry's valuation, stock price, and market status.
Is Raydiant Oximetry a public or private company?
Raydiant Oximetry is a private company.
What is the current stock price of Raydiant Oximetry?
Raydiant Oximetry is a private company, so its shares have no public market price. Caplight tracks Raydiant Oximetry's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Raydiant Oximetry worth (valuation)?
Valuation information for Raydiant Oximetry is not publicly available.
Can I buy Raydiant Oximetry stock?
Raydiant Oximetry shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Raydiant Oximetry's last funding round?
Raydiant Oximetry's most recent funding round was Grant on November 1, 2024.
Who are the main investors in Raydiant Oximetry?
Key investors in Raydiant Oximetry include Avestria Ventures, Cross Border Impact Ventures, VCapital.
Will Raydiant Oximetry IPO soon?
No public IPO plans have been announced for Raydiant Oximetry.
How can I track Raydiant Oximetry secondary market activity?
Caplight tracks bids, offers, and trades in Raydiant Oximetry's shares on secondary markets.